Who
Leonardo Viana Nicacio
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Corbus Pharmaceuticals Holdings; Chief Medical Officer, Protara Therapeutics.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 15 Apr 2025
- Last trade
- 16 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Aug 2026filed 17 Aug 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —58,333 at $0.00 | filing |
| 16 Aug 2026filed 17 Aug 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —191,676 at $0.00 | filing |
| 16 Aug 2026filed 17 Aug 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —191,676 at $0.00 | filing |
| 16 Aug 2026filed 17 Aug 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —58,333 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —158,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —158,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 15 Apr 2025filed 17 Apr 2025 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 15 Apr 2025filed 17 Apr 2025 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.